Dataset opportunity
Clearpointhealth — 医疗影像数据集机会
Clearpointhealth 持有的中等规模医疗影像数据集,可用于诊断人工智能和计算机视觉。
Score
48
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
42%
Action
数据共享协议
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球医疗诊断人工智能市场规模在 2023 年估值为 11 亿美元,复合年增长率为 25.2%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Concrete evidence this company actively cares about data — why it's ripe for the deal room.
- ✨Signal
专注于质量和安全数据报告
source ↗
Profile
Dataset profile
Type
医疗影像数据集
Modality
影像
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
中等
Accessibility
受限
Legal
公司所有 — GDPR 敏感(PII 审查)
Buyer persona
医疗人工智能与诊断影像公司
Clearpoint Health 持有一个来自其外科中心网络的实质性医疗影像数据集,涵盖多个专科和各种影像模式。这个丰富、多来源的集合,辅以业务和医疗记录,非常适合训练和验证旨在改善各种疾病检测和分析的诊断人工智能算法。
全球医疗诊断人工智能市场的价值凸显了其商业价值,该市场在2023 年的估值为11 亿美元,预计将以25.2% 的复合年增长率增长。尽管由于高度敏感的PHI以及 PIPEDA/PHIPA 法规存在访问复杂性,但该去标识化数据的稀有性和质量为人工智能开发人员提供了在这一快速扩张的市场中获得竞争优势的重大机会。⚠ 尽职调查(有价值的数据,可协商的访问权限):受 PIPEDA/PHIPA 法规管辖的高度敏感医疗和个人健康信息 (PHI);数据分布在多个外科中心和专科;需要进行大量去标识化和道德审查才能获得人工智能许可 · 公司:Kensington Capital Partners 的子公司。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据证实 Clearpointhealth 拥有一个独特的数据集,该数据集结合了医学影像以及相关的临床路径和患者结果数据。这一集成资产对于开发和验证下一代诊断人工智能模型至关重要,该市场预计每年增长超过 25%。对于医疗人工智能和诊断影像公司而言,这些数据为创建更准确、更具上下文感知能力的工具提供了直接途径,涵盖骨科和普外科等高价值专科。运营记录的包含还允许对新的人工智能驱动诊断的实际效率提升进行建模。
See dimension details ↓- Dataset Specificity66
主导的“医疗记录”,医疗保健行业,1 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity58
专有领域数据
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume46
2 条证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness46
定期
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value64
适用于诊断人工智能
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
买家需求极高,这得益于医疗诊断人工智能市场的快速增长,该市场正以 25.2% 的复合年增长率扩张。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility0
PII/受监管
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility0
高难度,Kensington Capital Partners 的子公司
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength50
2 种证据类型,2 条命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License62
所有权=公司所有,许可=GDPR 敏感
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence50
Kensington Capital Partners 的子公司
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation39
1 个数据需求信号(1 种类型)
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus92
盈余=高 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit67
⚠ 审查 — 该公司的核心业务是提供外科服务,而不是出售数据,但一家同名的美国公司 ClearPoint Health Solutions 出售数据相关服务,造成混淆。问题:提供的 URL (clearpointhealth.ca) 属于 Clearpoint Health Network,这是一家加拿大公司,运营着一个外科和医疗中心网络;Clearpoint Health Network 的核心业务是提供外科服务以支持公共卫生系统,而不是出售数据或人工智能;这家加拿大实体似乎是一家中小型企业,员工人数估计在 109 到 137 人之间;虽然它作为其运营的副产品产生了宝贵的专有医疗数据(影像、患者记录),但没有迹象表明它寻求将其货币化。
- Deep Qualification80
✓ 通过 — Clearpoint Health Network 是一个数据持有者;它运营着加拿大最大的独立外科中心网络,使得医学影像数据集作为其核心业务的副产品存在的可能性很大。然而,其隐私政策是通用的,并未明确患者数据去标识化和商业化的权利,这些数据高度敏感并受严格的加拿大法规(PIPEDA/PHIPA)管辖。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Medical records / imaging
持有者拥有直接与临床路径和患者结果相关联的医学影像,这是培训和验证诊断人工智能的关键组合,能够清晰地了解实际性能。
business_records
该数据集包括详细说明候诊名单管理和设施效率的运营文件,为对人工智能解决方案的经济和临床影响进行建模的公司提供了宝贵的实际背景。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Clearpointhealth Medical Imaging — a Moderate medical imaging dataset (Image modality) in the healthcare domain. Primary AI use-case: Diagnostic AI. Market signal: Global AI in Medical Diagnostics Market size was valued at USD 1.1 Billion in 2023, growing at a CAGR of 25.2% (source: Market.us).. Investment score 48.0/100 (confidence 0.42). Recommended action: Data Sharing Agreement.
From the marketplace
Explore live data opportunities
Westcoastrailways — 维护日志数据集机会
View opportunity →其他Productionbureau — 活动流数据集机会
View opportunity →mobilityAmco Group — 移动遥测数据集机会
View opportunity →